IL84845A0 - Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof - Google Patents

Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof

Info

Publication number
IL84845A0
IL84845A0 IL84845A IL8484587A IL84845A0 IL 84845 A0 IL84845 A0 IL 84845A0 IL 84845 A IL84845 A IL 84845A IL 8484587 A IL8484587 A IL 8484587A IL 84845 A0 IL84845 A0 IL 84845A0
Authority
IL
Israel
Prior art keywords
salt
certain
pharmaceutical compositions
carbazolone
derivative
Prior art date
Application number
IL84845A
Other languages
English (en)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868630075A external-priority patent/GB8630075D0/en
Priority claimed from GB878726424A external-priority patent/GB8726424D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL84845A0 publication Critical patent/IL84845A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL84845A 1986-12-17 1987-12-16 Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof IL84845A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868630075A GB8630075D0 (en) 1986-12-17 1986-12-17 Medicaments
GB878726424A GB8726424D0 (en) 1987-11-11 1987-11-11 Medicaments

Publications (1)

Publication Number Publication Date
IL84845A0 true IL84845A0 (en) 1988-06-30

Family

ID=26291706

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84845A IL84845A0 (en) 1986-12-17 1987-12-16 Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof

Country Status (15)

Country Link
US (1) US4845115A (US06566495-20030520-M00011.png)
EP (1) EP0275668B1 (US06566495-20030520-M00011.png)
JP (1) JP2608078B2 (US06566495-20030520-M00011.png)
KR (1) KR950013450B1 (US06566495-20030520-M00011.png)
AU (1) AU618520B2 (US06566495-20030520-M00011.png)
CY (1) CY1692A (US06566495-20030520-M00011.png)
DE (1) DE3782028T2 (US06566495-20030520-M00011.png)
DK (1) DK662687A (US06566495-20030520-M00011.png)
ES (1) ES2052585T3 (US06566495-20030520-M00011.png)
GR (1) GR3006255T3 (US06566495-20030520-M00011.png)
HK (1) HK36693A (US06566495-20030520-M00011.png)
IE (1) IE60991B1 (US06566495-20030520-M00011.png)
IL (1) IL84845A0 (US06566495-20030520-M00011.png)
NZ (1) NZ222950A (US06566495-20030520-M00011.png)
PH (1) PH25025A (US06566495-20030520-M00011.png)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190954A (en) * 1986-12-17 1993-03-02 Glaxo Group Limited Methods for the treatment of cognitive disorders
US5200414A (en) * 1986-12-17 1993-04-06 Glaxo Group Limited Methods for the treatment of cognitive disorders
GB8805269D0 (en) * 1988-03-04 1988-04-07 Glaxo Group Ltd Medicaments
US5229407A (en) * 1988-09-01 1993-07-20 Glaxo Group Limited Medicaments
GB8820651D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
US5225407A (en) * 1990-02-22 1993-07-06 Glaxo Group Limited 5-HT3 receptor antagonists for the treatment of autism
EP0492020A1 (en) * 1990-12-21 1992-07-01 Merrell Dow Pharmaceuticals Inc. Use of certain esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one and related compounds for treating cognitive disorders
EP0591434A4 (en) * 1991-06-26 1994-09-14 Sepracor Inc Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
WO1993000075A1 (en) * 1991-06-26 1993-01-07 Sepracor, Inc. Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron
CA2157671A1 (en) * 1993-03-08 1994-09-15 Kiyotaka Katsuta Medicament for treating or preventing cerebrovascular diseases
ZA989365B (en) * 1997-10-15 1999-04-15 Boehringer Mannheim Pharm Corp Preparation for treating alzheimer's disease
DE60016892T2 (de) * 1999-01-07 2005-12-15 P.N. Gerolymatos S.A., Kryoneri Verwendung von phanquinon zur behandlung und vorbeugung von gedächtnisschwund
AU779696B2 (en) * 1999-03-01 2005-02-10 Sepracor, Inc. Methods for treating apnea and apnea disorders using optically pure R(+)ondansetron
US20020115707A1 (en) * 2001-01-11 2002-08-22 Rami Lidor-Hadas Process for preparing pure ondansetron hydrochloride dihydrate
GB0701970D0 (en) 2007-02-01 2007-03-14 Wilson Stuart Treatment of protein aggregation diseases
US20100298397A1 (en) * 2009-05-19 2010-11-25 Singh Nikhilesh N Method of treatment of obsessive compulsive disorder with ondansetron

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
DE3445377A1 (de) * 1983-12-23 1985-07-04 Sandoz-Patent-GmbH, 7850 Lörrach Carbocylische und heterocyclische carbonsaeureester und -amide von ueberbrueckten und nicht ueberbrueckten cyclischen stickstoffhaltigen aminen oder alkoholen
BE901576A (fr) * 1984-01-25 1985-07-25 Glaxo Group Ltd Composes heterocycliques.
EP0191562B1 (en) * 1985-01-23 1991-07-10 Glaxo Group Limited Tetrahydrocarbazolone derivatives
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
EP0405617A3 (en) * 1985-03-14 1992-11-25 Beecham Group P.L.C. Medicaments for the treatment of anxiety
US4624961A (en) * 1985-04-17 1986-11-25 A. H. Robins Company, Incorporated Method for enhancing memory or correcting memory deficiency with arylamidopyrazolidines and arylamidodiazabicycloalkanes
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
HU895334D0 (en) * 1986-07-30 1990-01-28 Sandoz Ag Process for the preparation of nasal pharmaceutical compositions

Also Published As

Publication number Publication date
NZ222950A (en) 1997-06-24
KR950013450B1 (ko) 1995-11-08
ES2052585T3 (es) 1994-07-16
AU8261487A (en) 1988-06-23
CY1692A (en) 1994-01-14
EP0275668B1 (en) 1992-09-30
JP2608078B2 (ja) 1997-05-07
IE60991B1 (en) 1994-09-07
DK662687D0 (da) 1987-12-16
DE3782028D1 (de) 1992-11-05
GR3006255T3 (US06566495-20030520-M00011.png) 1993-06-21
EP0275668A2 (en) 1988-07-27
IE873414L (en) 1988-06-17
PH25025A (en) 1991-01-28
US4845115A (en) 1989-07-04
AU618520B2 (en) 1992-01-02
HK36693A (en) 1993-04-23
JPS63253083A (ja) 1988-10-20
KR880007074A (ko) 1988-08-26
EP0275668A3 (en) 1989-10-11
DE3782028T2 (de) 1993-02-18
DK662687A (da) 1988-06-18

Similar Documents

Publication Publication Date Title
GB2222772B (en) Pharmaceutical compositions
GB2219940B (en) Pharmaceutical compositions
GB8710965D0 (en) Pharmaceutical compositions
IL84845A0 (en) Pharmaceutical compositions comprising a certain carbazolone derivative or a salt thereof
EG18652A (en) Pharmaceutical compositions
HU896876D0 (en) Pharmaceutical compositions
IL79195A0 (en) Pharmaceutical compositions containing a styrylnaphthalene derivative
IL79194A0 (en) Pharmaceutical compositions containing a styrylnaphthalene derivative
GB2217202B (en) Trimelamol-containing pharmaceutical compositions
GB8830406D0 (en) Pharmaceutical compositions
IL84929A (en) Pharmaceutical compositions comprising enkephalinase or derivatives thereof
GB8804189D0 (en) Pharmaceutical compositions
GB8830169D0 (en) Pharmaceutical compositions
GB8826289D0 (en) Pharmaceutical compositions
GB8814146D0 (en) Pharmaceutical compositions
GB8822603D0 (en) Pharmaceutical compositions
ZA897139B (en) Pharmaceutical compositions
GB8809840D0 (en) Pharmaceutical compositions
ZA893224B (en) Pharmaceutical compositions
GB8809650D0 (en) Pharmaceutical compositions
GB8822507D0 (en) Pharmaceutical compositions
GB8815443D0 (en) Pharmaceutical compositions
GB8808117D0 (en) Pharmaceutical compositions
GB8820265D0 (en) Pharmaceutical compositions
GB8830174D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees